| 2024/05/03 17:33:01 | |
|---|---|
| Price | |
| 0.0012 CHF | |
| Difference | -76.92% (-0.00) |
General attributes
| ISIN | CH1260041939 |
| Symbol | OBSN |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 0 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 0.0012 CHF (39,800) |
| Ask (Ask size) | 0.0012 CHF (11,245) |
| Open | 0.005 CHF |
| High | 0.0058 CHF |
| Low | 0.0012 CHF |
| Close (prev. day) | 0.0052 CHF |
| VWAP | 0.00435 CHF |
| Volume (pcs) | 2,351,202 |
| Trading volume | 10,228.74 |
| Number of trades | 51 |
| Last size | 3,755 |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: OBSEVA SA CHF0.076923 |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/07/12 |
|
Global Equity Ratings |
|
| 2024/06/21 |
|
Global Equity Ratings |
|
| 2024/06/14 |
|
Global Equity Ratings |
|
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/05/03 17:33:01 | |
|---|---|
| Price | |
| 0.0012 CHF | |
| Difference | -76.92% (-0.00) |
General attributes
| ISIN | CH1260041939 |
| Symbol | OBSN |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 0 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 0.0012 CHF (39,800) |
| Ask (Ask size) | 0.0012 CHF (11,245) |
| Open | 0.005 CHF |
| High | 0.0058 CHF |
| Low | 0.0012 CHF |
| Close (prev. day) | 0.0052 CHF |
| VWAP | 0.00435 CHF |
| Volume (pcs) | 2,351,202 |
| Trading volume | 10,228.74 |
| Number of trades | 51 |
| Last size | 3,755 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -97.39% | -98.66% | -99.96% |
| Perf (abs.) | -0.04 | -0.09 | -2.76 |
| Beta | -164.32 | -77.01 | -11.11 |
| Volatility | 385.99 | 277.68 | 195.40 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 0.0058 CHF (910,404) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 0.0079 CHF (610,179) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 0.0305 CHF (439,836) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 0.0484 CHF (238,373) |
| YTD High | date | 0.0800 CHF (2024/01/23) |
| YTD Low | date | 0.0012 CHF (2024/05/03) |
| 52 Weeks High | date | 0.0890 CHF (2023/05/04) |
| 52 Weeks Low | date | 0.0012 CHF (2024/05/03) |
All listings for OBSEVA SA CHF0.076923
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| SIX Swiss Exchange | 2024/05/03 | 17:33 | 0.0012 CHF | 0.01 | 51 |
| Frankfurt | 2019/06/28 | 15:43 | 9.22 EUR | 0.00 | 2 |
| FINRA other OTC Issues | 2024/07/16 | 21:52 | 0.0000 USD | 0.00 | 3 |
| Berlin | 2019/06/28 | 08:02 | 9.12 EUR | 0.00 | 1 |
Company Logo
Contact Details
| OBSEVA SA |
| - - |
| Chemin des Aulx, 12, Plan-les-Ouates - 1228 Genf |
| Telefon: +41-22-552-38-40 |
| Fax: + |
| E-mail: contact@obseva.ch |
PDF Downloads
| Company report: OBSEVA SA CHF0.076923 | |
Company Profile
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland. |
Members of Management Board
| Fabien de Ladonchamps | Chairman of Managing Board |
Board of directors
| Luigi Marro | Member of the administrative board |
| Ernest Loumaye | Chairman of the administrative boar |